INTRANASAL DRUG DELIVERY DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Regional Analysis

To learn more about this report, request sample copy

North America dominates the intranasal drug delivery devices globally with an estimated market share of 38.2% in 2024,  due to the presence of major device manufacturers as well as favorable reimbursement policies for new drug delivery technologies in the region. The U.S. accounts for the maximum share due to the large healthcare expenditure and adoption of advanced medical devices. The medical devices industry is one of the most developed industries in the U.S., encouraging continuous innovations. Thus, there has been increasing demand for improved drug delivery methods like intranasal devices.

North America dominates due to the presence of major device manufacturers and supportive reimbursement policies. The Asia Pacific region is expected to witness highest growth due to improved healthcare infrastructure, low-cost manufacturing opportunities and rising chronic disease prevalence.

Asia Pacific region is poised to be the fastest growing market for intranasal drug delivery due to rising healthcare infrastructure and growing medical tourism industry across Asia Pacific countries. The large patient pool suffering from chronic conditions like diabetes and asthma that require intranasal drug delivery also drives the market growth. Countries like India and China offer low-cost manufacturing options, attracting many global device companies to establish production bases in the region. This increases the availability and affordability of intranasal devices in Asia Pacific.